Philip Keiser Selected Research

Philip Keiser Research Topics

3	Hypersensitivity (Allergy) 03/2007 - 05/2002
3	HIV Infections (HIV Infection) 03/2007 - 02/2002
1	COVID-19 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013
1	Acute Kidney Injury (Acute Renal Failure) 09/2010
1	Hepatitis B 04/2007
1	Coinfection 04/2007
1	Hyperlipidemias (Hyperlipidemia) 03/2007
1	Exanthema (Rash) 07/2003
1	Human Influenza (Influenza) 07/2003
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2003
1	Pharyngitis (Sore Throat) 07/2003
1	Cough 07/2003

2	NucleosidesIBA 03/2007 - 05/2002
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2007 - 05/2002
2	abacavir (Ziagen)FDA Link 03/2007 - 07/2003
1	Oxygen (Dioxygen)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2013
1	CreatinineIBA 09/2010
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2007
1	Zidovudine (Retrovir)FDA LinkGeneric 03/2007
1	Lamivudine (Epivir)FDA Link 03/2007
1	abacavir, lamivudine, and zidovudine drug combination FDA Link 05/2002

4	Therapeutics 01/2013 - 05/2002
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Art Therapy 01/2013
1	Highly Active Antiretroviral Therapy (HAART) 02/2002